Shanghai Sanyou Medical Co., Ltd.

Shanghai Stock Exchange 688085.SS

Shanghai Sanyou Medical Co., Ltd. Net Income for the year ending December 31, 2023: USD 13.46 M

Shanghai Sanyou Medical Co., Ltd. Net Income is USD 13.46 M for the year ending December 31, 2023, a -51.31% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Shanghai Sanyou Medical Co., Ltd. Net Income for the year ending December 31, 2022 was USD 27.65 M, a -5.73% change year over year.
Shanghai Sanyou Medical Co., Ltd. Net Income for the year ending December 31, 2021 was USD 29.33 M, a 61.49% change year over year.
Shanghai Sanyou Medical Co., Ltd. Net Income for the year ending December 31, 2020 was USD 18.16 M, a 29.31% change year over year.
Shanghai Sanyou Medical Co., Ltd. Net Income for the year ending December 31, 2019 was USD 14.05 M, a 55.47% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shanghai Stock Exchange: 688085.SS

Shanghai Sanyou Medical Co., Ltd.

CEO	Dr. Mingyan Liu
IPO Date	April 9, 2020
Location	China
Headquarters	Medical Apparatus Gdn of Zhangjiang Hi-T
Employees	466
Sector	Technology
Industries 3D Printing Automotive Parts Composite Materials Furniture Medical Instruments Plastics Robotics Steel

Description

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and z-minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee system, knee system, and palm and wrist systems. Shanghai Sanyou Medical Co., Ltd. is based in Shanghai, China.

Key trends

Past 5 years